Oncobiology Symposium
ISSN: 2966-4438
Papers (10)
-
ANTITUMOR EVALUATION IN VITRO OF NAPHTHOQUINONES MANNICH BASES FOR POSSIBLE TREATMENT OF OSCC
Vol 1, 2020 -131228 -
Determination of anti-tumor activity of naphthoquinone-triazole-coumarin hybrids for possible treatment of Oral Squamous Cell Carcinoma
Vol 1, 2020 -131259 -
EVALUATION OF NAPHTHOQUINONES MANNICH BASES AGAINST ORAL SQUAMOUS CELLS CARCINOMA
Vol 2, 2021 -142268 -
DETERMINATION OF ANTI-TUMOR ACTIVITY OF NAPHTHOQUINONE-TRIAZOLE-COUMARIN HYBRIDS FOR POSSIBLE TREATMENT OF ORAL SQUAMOUS CELL CARCINOMA
Vol 2, 2021 -142317 -
ANTITUMOR ACTIVITY OF NAPHTHOQUINONES MANNICH BASES AGAINST ORAL SQUAMOUS CELLS CARCINOMA
Vol 3, 2022 -155037 -
NAPHTHOQUINONE-TRIAZOLE-COUMARIN HYBRIDS INDUCES AUTOPHAGY POSSIBLY BY PKM2 INHIBITION IN ORAL SQUAMOUS CELL CARCINOMA
Vol 3, 2022 -155128 -
INDUCTION OF AUTOPHAGY IN ORAL SQUAMOUS CELL CARCINOMA BY NAPHTHOQUINONE-TRIAZOLE-COUMARIN HYBRIDS POSSIBLY BY PKM2 INHIBITION
-166858 -
ASSESSMENT OF BIOLOGICAL ACTIVITY OF SYNTHETIC COUMARIN-BASED HYBRIDS WITH NAPHTHOQUINONE AND TRIAZOLE SYSTEMS AGAINST ORAL SQUAMOUS CELL CARCINOMA
-167098 -
DETERMINATION OF INHIBITORY EFFECT OF PKM2 ENZYME AND ANTITUMORAL ACTIVITY OF NOVEL COUMARIN-NAPHTHOQUINONE HYBRIDS
-315236 -
INVESTIGATION OF THE POTENTIAL ANTI-TUMORAL ACTIVITY OF NAFTOQUINONE BM23 IN GLIOBLASTOMA CELLS
VOL XVIII, Ano 2024 -314843
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
